CLOSE X
GO

HDFC Pharma and Healthcare Fund-Reg(G)

very highequitypharma & health care
16.18 0.22(1.38%) NAV as on 04 Feb 2025
-5.41 % 1 M
34.7 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.14

As on 31 Dec, 2024
age-icon Age :

1 yrs 4 m

Since 04 10 ,2023
exit_load Exit Load :

1%

aum AUM :

1,577.12 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.04

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Nikhil Mathur

LATEST ASSET & PORTFOLIO ALLOCATION

as on Dec 31 ,2024
Others 1.96 %
Equity 98.04 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.22 %
Cipla Ltd.7.89 %
Divi's Laboratories Ltd.7.18 %
Lupin Ltd.6.17 %
Aster DM Healthcare Ltd.3.89 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs78.81
Hospital & Healthcare Services17.87
Business Support1.36
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-2025
NAV in Rs (as on 04-Feb-2025)12.2916.18
Net Assets(Rs Crores) (as on 04-Feb-2025) 800.65 1577.12
Scheme Returns(%)(Absolute)23.3030.44
B'mark Returns(%)(Absolute)NANA
Category Rank66/902/98

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

HDFC Pharma and Healthcare Fund-Reg(G)Very HighEquity16.180.22(1.38%)NAV As on 04 Feb, 202504-Oct-2023Inception Date1,577.12AUM In Cr.34.70%1YNA%3YNA%5Y43.59%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity422.096.90(1.66%)NAV As on 04 Feb, 202514-Jul-1999Inception Date3,628.03AUM In Cr.29.31%1Y23.55%3Y27.76%5Y16.50%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.450.48(1.30%)NAV As on 04 Feb, 202513-Jul-2018Inception Date5,320.29AUM In Cr.29.99%1Y23.27%3Y28.49%5Y22.26%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.710.44(1.51%)NAV As on 04 Feb, 202528-Dec-2015Inception Date1,287.45AUM In Cr.24.56%1Y20.02%3Y25.20%5Y12.69%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors